Manipal Health Enterprises IPO Review 2026: Financials & Risks

Manipal Health Enterprises IPO is a mainboard offering from India's largest multi-specialty hospital network by bed capacity, operating under the well-known "Manipal Hospitals" brand. The company, part of the Manipal Group founded by Dr. T.M.A. Pai, runs a pan-India chain of hospitals, clinics and diagnostic centres spanning tertiary and quaternary care, organ transplants, oncology, cardiology, neurology and orthopaedics.

The ₹9,275.21 crore IPO is a mix of a ₹8,000 crore fresh issue and a ₹1,275.21 crore offer for sale, making it one of the largest healthcare listings in India in recent years. The fresh issue proceeds are earmarked mainly for debt repayment at a material subsidiary and a minority-stake acquisition in Sahyadri Hospitals.

For issue details, subscription numbers and the application link, visit the Manipal Health Enterprises IPO page on IPO Ji.

Manipal Health Enterprises IPO — Quick Overview

Of the ₹9,275.21 crore issue, the fresh issue component of 13,55,93,220 shares (aggregating up to ₹8,000 crore) will go to the company, while the offer for sale of 2,16,13,834 shares (aggregating up to ₹1,275.21 crore) will go to selling shareholders. Kfin Technologies Limited is the registrar, and the lead managers are Kotak Mahindra Capital Company Limited, Axis Capital Limited, Goldman Sachs (India) Securities Private Limited, Jefferies India Private Limited, JP Morgan India Private Limited, UBS Securities India Private Limited and DBS Bank India Limited.

For the complete lot-size table, live subscription tracker and application link, see the Manipal Health Enterprises IPO detail page on IPO Ji.

About Manipal Health Enterprises Limited

Manipal Health Enterprises Limited is one of India’s largest multi-specialty healthcare providers, operating hospitals, clinics and diagnostic centres across the country. It offers advanced treatments in organ transplants, oncology, cardiology, neurosciences, orthopaedics, renal sciences and preventive care.

As of March 31, 2026, the company operated 49 hospitals with 13,037 licensed beds across 14 states and union territories. It was the largest private hospital network in India by bed capacity and the second-largest by hospital count. Its growth has been supported by acquisitions such as Columbia Asia, AMRI Hospitals, Medica Synergie and Sahyadri Group. The network employed over 11,000 doctors, 11,000 nurses and 6,300 paramedics.

Manipal Health Enterprises Financial Performance

Based on the Restated Consolidated Financial Information in the RHP, for the financial years ended March 31, 2024, 2025 and 2026:

• Revenue from operations increased from ₹6,171.63 crore in FY24 to ₹8,242.25 crore in FY25, and further to ₹10,335.75 crore in FY26 — a CAGR of 29.41%.
• Profit for the year rose from ₹533.20 crore in FY24 to ₹1,081.67 crore in FY25, before declining to ₹916.52 crore in FY26.
• EBITDA (excluding exceptional items) increased from ₹1,776.60 crore in FY24 to ₹2,795.94 crore in FY26.
• Total assets increased from ₹10,818.83 crore in FY24 to ₹14,072.08 crore in FY25, and rose sharply to ₹24,864.50 crore in FY26.
• Net worth (equity attributable to owners) grew from ₹4,015.54 crore in FY24 to ₹5,847.34 crore in FY25 and further to ₹8,426.09 crore in FY26.
• Total borrowings increased from ₹3,943.98 crore in FY24 to ₹4,766.83 crore in FY25, and rose sharply to ₹10,553.43 crore in FY26.
• Net Asset Value per share stood at ₹72.55 as of March 31, 2026.

Source: RHP of Manipal Health Enterprises Limited, dated July 23, 2026

Manipal Health Enterprises Key Strengths

1. Largest pan-India hospital network by bed capacity: 13,037 licensed beds across 49 hospitals in 14 states and union territories as of March 31, 2026, with leadership positions in Karnataka, Maharashtra & Goa, and Eastern India.
2. Only private chain leading three metros simultaneously: Leadership by bed capacity in Bengaluru, Kolkata and Pune, giving it a mix of dense metro coverage and non-metro reach.
3. Recognised brand and clinical talent base: The "Manipal Hospitals" brand served 6.30 million patients in FY26 (pro forma basis) and the network includes over 11,000 doctors and a similar number of nurses.
4. Advanced clinical infrastructure: 18 soft-tissue robots, 19 linear accelerators, 44 MRI scanners, 23 surgical robots and 58 catheterisation labs supported complex procedures including transplants, robotic surgery and interventional cardiology.
5. Strong and consistent growth: Revenue from operations grew at a 29.41% CAGR and profit for the year at a 31.11% CAGR between FY24 and FY26, alongside a negative working capital cycle.
6. Proven acquisition and integration playbook: A track record of integrating hospital groups of varying sizes — Columbia Asia, Vikram Hospital, AMRI, Medica Synergie and, most recently, Sahyadri Group — while improving their margins post-acquisition.

Manipal Health Enterprises Key Weaknesses

1. Sharp rise in borrowings: Total borrowings more than doubled from ₹4,766.83 crore in FY25 to ₹10,553.43 crore in FY26, largely tied to funding recent acquisitions, including the Sahyadri Group.
2. Revenue concentration in Karnataka: The state accounted for 46.40% of revenue from operations in FY26 (down from 59.98% in FY24, but still the single largest exposure by geography).
3. Specialty concentration: Cardiac sciences, oncology, neurosciences, gastro sciences, orthopaedics and renal sciences (CONGO-R) together accounted for 64.30% of gross inpatient revenue in FY26.
4. Profit decline in FY26 despite revenue growth: Profit for the year fell from ₹1,081.67 crore in FY25 to ₹916.52 crore in FY26, and basic EPS fell from ₹9.25 to ₹7.71 — partly reflecting a larger post-bonus-issue share base following the company's 2:1 bonus issue and equity sub-division.
5. Integration risk from recent acquisitions: The Sahyadri Group acquisition (completed October–December 2025) and other recent deals carry execution risk around realising anticipated synergies and integrating systems and clinical protocols.

Manipal Health Enterprises IPO Allotment Status

Allotment is tentatively expected around August 3, 2026, with listing tentatively scheduled for August 5, 2026 on BSE and NSE. Once finalised, check your status via:

• The IPO Ji app or website
• BSE or NSE websites
• Kfin Technologies (registrar) website

You'll need your PAN, application number or Demat account details.

Check the Manipal Health Enterprises IPO allotment status on IPO Ji for quick updates.

How to Apply for Manipal Health Enterprises IPO on IPO Ji

1. Open the IPO Ji App (Play Store/App Store) or visit ipoji.com.
2. Search for Manipal Health Enterprises IPO.
3. Review the price band, lot size and dates.
4. Select your Demat account and enter the number of lots.
5. Submit using your registered UPI ID and approve the mandate before the deadline.

The application amount stays blocked in your account and is debited only on allotment. ASBA via net banking or a supported broker also works.